Wed, July 27, 2022
Tue, July 26, 2022
Mon, July 25, 2022
Fri, July 22, 2022
Thu, July 21, 2022

Vikram Purohit Maintained (TBPH) at Sell with Decreased Target to $10 on, Jul 25th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-10-on-jul-25th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Vikram Purohit of Morgan Stanley, Maintained "Theravance Biopharma, Inc." (TBPH) at Sell with Decreased Target from $11 to $10 on, Jul 25th, 2022.

Vikram has made no other calls on TBPH in the last 4 months.



There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with Vikram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Vikram


  • David Risinger of "SVB Leerink" Initiated at Buy and Held Target at $12 on, Monday, May 23rd, 2022

Publication Contributing Sources